Question

In: Finance

In the attached table, you are given valuation ratios for Eli Lily & Co. as well...

In the attached table, you are given valuation ratios for Eli Lily & Co. as well as select competitors and the pharmaceutical and biotech industry. Using this data, assess whether Eli Lily & Co. is correctly valued. Explain your rationale. If, in your opinion, it is not correctly valued, explain whether it is overvalued or undervalued and the basis for your opinion and what ratios support your conclusion.

Row headers in order: Price to earnings (P/E), Price to next year expected earnings, Price-earnings-growth (PEG), Price to operating profit (P/OP), Price to sales (P/S), Price to book value (P/BV)

Eli Lilly & Co.

Amgen Inc.

Biogen Inc.

Gilead Sciences Inc.

Pfizer Inc.

Regeneron Pharmaceuticals Inc.

Vertex Pharmaceuticals Inc.

Zoetis Inc.

Pharmaceuticals & Biotechnology

Price to earnings (P/E)

17.79

17.37

10.00

17.96

12.23

28.08

58.33

40.35

23.05

Price to next year expected earnings

15.45

15.25

7.52

14.19

11.62

23.07

53.11

28.82

21.54

Price-earnings-growth (PEG)

1.17

1.25

0.30

0.68

2.32

1.29

5.93

1.01

3.28

Price to operating profit (P/OP)

29.75

14.08

8.36

22.56

15.11

26.88

57.32

30.77

20.21

Price to sales (P/S)

6.63

6.13

4.10

4.37

3.85

7.55

16.49

9.67

4.95

Price to book value (P/BV)

56.77

14.08

4.41

4.29

3.15

5.36

11.28

22.35

5.49

Solutions

Expert Solution

The stock is valued low as compared to its competitor. It has a slightly higher PE than Biogen and pfizer, however it has a very low PE and Leading PE ratio compared to its competitors Vertex and Zoetis.

Though its PE ratio is higher than Pfizer, but its PEG ratio is comparatively very lower than Pfizer, thus the PE to growth opportunities isnt even better than its competitors. The PEG isnt even better than most of its competitors.

Price to Operating Earnings shows a better return to the investors. At comparable ratio to the industry Leading companies like Zoetis and vertix
A very higher Price to Book Value, as compared to its competitors is a strong indicator. that the stock is highly over valued.
In a nutshell the company Eli Lily & Co ltd is not a share worth investing. Its valuations shows it is over valued, with lower growth opportunities. It may not be a good option to invest, as compared to its competitors


Related Solutions

Given the BS and IS for Simmons Mfg. Co., compute the ratios on the next page....
Given the BS and IS for Simmons Mfg. Co., compute the ratios on the next page. For each ratio indicate if Simmons is doing better or worse than the industry average by providing an “x” in the appropriate box. SHOW CALCULATIONS ON NEXT PAGE BELOW THE CHART. 20 points SIMMONS MANUFACTURING COMPANY Balance Sheet       Assets                                                                          Liabilities and Stockholders’ Equity             Cash                            $ 15,000                                 Accounts Payable                   $ 21,000       Accts. Receivable           22,000                                 Notes Payable                             20,000       Inventory                   ...
Can you do a comparable valuation for alibaba? Use the easiest ratios you can and make...
Can you do a comparable valuation for alibaba? Use the easiest ratios you can and make it less than 3 minutes
Examine the financial ratios, stock valuation and news about Amazon. Do you see the firm’s share...
Examine the financial ratios, stock valuation and news about Amazon. Do you see the firm’s share price rising/decreasing in the near-, intermediate- and long-term? Do you believe the firm has a stable future of sustainable growth, currently stagnant, or is heading for financial failure? Why?
1. Examine the financial ratios, stock valuation and news about Walmart. Do you see the firm’s...
1. Examine the financial ratios, stock valuation and news about Walmart. Do you see the firm’s share price rising/decreasing in the near-, intermediate- and long-term? Do you believe the firm has a stable future of sustainable growth, currently stagnant, or is heading for financial failure? Why? 2. Would you invest in Walmart? Why or why not? through their 10 k filling or using recent price
1. Examine the financial ratios, stock valuation and news about Amazon. Do you see the firm’s...
1. Examine the financial ratios, stock valuation and news about Amazon. Do you see the firm’s share price rising/decreasing in the near-, intermediate- and long-term? Do you believe the firm has a stable future of sustainable growth, currently stagnant, or is heading for financial failure? Why? 2. Would you invest in Amazon? Why or why not?
You are asked to evaluate Rising Star Co. using the free cash flow valuation approach. You...
You are asked to evaluate Rising Star Co. using the free cash flow valuation approach. You have collected the following information: Rising Star has net income of $250 million, depreciation of $90 million, capital expenditures of $170 million, and an increase in working capital of $40 million. Rising Star will finance 40% of the increase in net fixed assets (capital expenditures less depreciation) and 40% of the increase in working capital with debt financing. Interest expenses are $150 million. The...
The code file is attached. Portion of the code is given (1, 2, 3, 4). You...
The code file is attached. Portion of the code is given (1, 2, 3, 4). You have to write the code for the remaining items (5, 6, 7). #include <iostream> using namespace std; struct node { int data; node* next; }; node* head=NULL; void appendNode(int value) { node *newNode, *curr; newNode = new node(); newNode->data=value; newNode->next=NULL; if (!head) head=newNode; else { curr=head; while (curr->next) curr = curr->next; curr->next = newNode; } } void insertNode(int value) { node *newNode, *curr, *previous;...
You are given the following information concerning Baron Co. Calculate the WACC for Baron Co. Debt:...
You are given the following information concerning Baron Co. Calculate the WACC for Baron Co. Debt: 17,958 5% coupon bonds outstanding, quoted at 105, with 20 years to maturity. These bonds pay interest semiannually. Common Stock: 350,000 shares common stock selling for $56.02 per share. The stock has a beta of 1.49. Preferred Stock: 10,000 shares of preferred stock with a dividend of $5.20 per share. It is currently selling at $106.37 per share. Market: The market premium is 7.5%,...
You are given the following information concerning Baron Co. Calculate the WACC for Baron Co. Debt:...
You are given the following information concerning Baron Co. Calculate the WACC for Baron Co. Debt: 11,162 5% coupon bonds outstanding, quoted at 105, with 20 years to maturity. These bonds pay interest semiannually. Common Stock: 350,000 shares common stock selling for $52.86 per share. The stock has a beta of 1.39. Preferred Stock: 10,000 shares of preferred stock with a dividend of $5.20 per share. It is currently selling at $108.09 per share. Market: The market premium is 7.5%,...
You are given the following information concerning Baron Co. Calculate the WACC for Baron Co. Debt:...
You are given the following information concerning Baron Co. Calculate the WACC for Baron Co. Debt: 10,416 5% coupon bonds outstanding, quoted at 105, with 20 years to maturity. These bonds pay interest semiannually. Common Stock: 350,000 shares common stock selling for $56.88 per share. The stock has a beta of 1.00. Preferred Stock: 10,000 shares of preferred stock with a dividend of $5.20 per share. It is currently selling at $101.09 per share. Market: The market premium is 7.5%,...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT